Biologists discover super-enhancers that switch on breast cancer genes

India daily virus cases double to 200,000 in 10 days
15 April 2021
Designing better antibody drugs with artificial intelligence
15 April 2021

Biologists discover super-enhancers that switch on breast cancer genes

Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with a high fatality rate. Currently, chemotherapy is the major treatment option, but the clinical result is unsatisfactory. A research team led by biologists at City University of Hong Kong (CityU) has identified and characterized a set of specific super-enhancers that stimulate the activity of the related critical cancer genes. The research has also discovered that the deletion of certain specific super-enhancers can reduce tumor cell growth. The latest findings may help discover new effective drug targets for TNBC patients to improve their survival chance.

Comments are closed.